July 2019 in “International journal of contemporary medical research”
This study found that dyslipidemia was more common in male patients with androgenetic alopecia than in controls, particularly among those with severe AGA, suggesting a higher risk of altered serumlipids.
February 2019 in “Journal of Pakistan Association of Dermatology”
This study found that abnormalserumlipidlevels were prevalent among male patients with androgenetic alopecia, with high triglycerides and low HDL observed frequently.
April 2018 in “Journal of Investigative Dermatology”
This study found that sensitive scalp is characterized by increased pH levels, redness, altered sebum composition, and a disrupted microbiome, suggesting these features could inform treatment approaches.
This study found that early-onset male androgenetic alopecia is associated with abnormallipid metabolism and lower levels of certain serum markers, which may serve as risk factors or protective factors for the condition.
A permanent hair loss solution could involve reprogramming hair follicles to resist DHT using mRNA and siRNA. However, high costs, safety concerns, and the pharmaceutical industry's preference for ongoing treatments over one-time cures are major obstacles, with finasteride and minoxidil remaining standard treatments.